Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.22.2.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of Changes in Fair Value of Level 3 Valued Instruments

The following tables present changes in fair value of level 3 valued instruments as of and for the nine months ended September 30, 2022 and 2021:

 

Schedule of Changes in Fair Value of Level 3 Valued Instruments

    vivoPharm Business  
Balance – December 31, 2021   $ 11,000  
Additions     -  
Measurement adjustments     (5,528 )
Settlement     -  
Balance – September 30, 2022   $ 5,472  

 

    2020
Convertible Note
    Warrant     Embedded Derivative  
Balance – December 31, 2020   $ -     $ -     $ 1,690  
Additions     3,746       635       325  
Measurement adjustments     4       (214 )     250  
Settlement     (3,750 )     (421 )     (2,265 )
Balance – September 30, 2021   $ -     $ -     $ -